Background
Dr. Shirkhan Amikishiyev is a physician–scientist specialized in internal medicine and rheumatology. After completing his medical education at Azerbaijan Medical University, he specialized in internal medicine and rheumatology at Istanbul Faculty of Medicine and continued his clinical and academic career at leading medical institutions in Türkiye.
He currently serves as a lecturer and researcher at the Faculty of Medicine and Health Sciences of Qarabağ University. His scientific interests include rheumatology, systemic autoimmune and autoinflammatory diseases, clinical immunology, and the development of clinical approaches in medical education.
Dr. Amikishiyev is recognized for his scientific publications in internationally indexed journals and research presentations at prestigious international congresses.
Degrees
Azerbaijan Medical University, Faculty of General Medicine and Preventive Medicine, (2005–2011)
Istanbul University, Istanbul Faculty of Medicine, Residency in Internal Medicine, (2013–2017)
Istanbul University, Istanbul Faculty of Medicine, Fellowship (Subspecialty Training) in Rheumatology, (2018–2022)
Awards
“Preliminary Criteria Study in COVID-19-Related Pulmonary Macrophage Activation Syndrome”
Traditional Internal Medicine Days – Interactive Update 2022
Istanbul Faculty of Medicine
First Prize – Oral Presentation (2022)
“Mortality and Associated Factors in Patients with Systemic Sclerosis with Pulmonary Arterial Hypertension: Analysis of 44 Patients from a Single Center”
Rheumatology Target 2023 Symposium
First Prize – Oral Presentation (2023)
Research Interests
Clinical research in rheumatology and internal medicine
Systemic sclerosis (scleroderma): disease activity, rituximab therapy, pulmonary hypertension, and renal crisis
Interstitial lung disease (ILD) and progressive lung involvement
Autoinflammatory diseases and genetic phenotypes (MEFV, NLRP1, etc.)
Hereditary periodic fever syndromes and genetic diagnostics
Behçet’s disease: NETosis, disease activity, and genetic associations
COVID-19 and hyperinflammation (MAS), treatment response prediction
Infections and complications in rheumatic diseases
Pulmonary hypertension in connective tissue diseases
Clinical immunology and systemic autoinflammatory phenotypes
Infections in hematological patients (especially multiple myeloma and stem cell transplantation)
Clinical nutrition and malnutrition
Metabolic syndrome and endothelial dysfunction (vitamin D, adropin)
Case reports and analysis of rare clinical conditions